BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
20.99
-1.80 (-7.90%)
Apr 10, 2025, 4:00 PM EDT - Market closed

BioLife Solutions Market Cap

BioLife Solutions has a market cap or net worth of $984.57 million as of April 10, 2025. Its market cap has increased by 15.61% in one year.

Market Cap
984.57M
Enterprise Value
905.53M
1-Year Change
15.61%
Ranking
Category
Stock Price
$20.99

Market Cap Chart

Since December 1, 1998, BioLife Solutions's market cap has increased from $4.30M to $984.57M, an increase of 22,797.05%. That is a compound annual growth rate of 22.88%.

History

DateMarket Cap% Change
Apr 9, 20251.07B-11.05%
Dec 31, 20241.20B68.30%
Dec 29, 2023715.50M-8.07%
Dec 30, 2022778.30M-49.86%
Dec 31, 20211.55B18.87%
Dec 31, 20201.31B294.62%
Dec 31, 2019330.90M48.65%
Dec 31, 2018222.60M172.13%
Dec 29, 201781.80M295.17%
Dec 30, 201620.70M-22.18%
Dec 31, 201526.60M34.34%
Dec 31, 201419.80M-53.08%
Dec 31, 201342.20M78.06%
Dec 31, 201223.70M577.14%
Dec 30, 20113.50M-16.67%
Dec 31, 20104.20M-45.45%
Dec 31, 20097.70M266.67%
Dec 31, 20082.10M-50.00%
Dec 31, 20074.20M-12.50%
Dec 29, 20064.80M220.00%
Dec 30, 20051.50M36.36%
Dec 31, 20041.10M-21.43%
Dec 31, 20031.40M-6.67%
Dec 31, 20021.50M-42.31%
Dec 31, 20012.60M-57.38%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 628.53B
UnitedHealth Group 536.17B
Johnson & Johnson 351.40B
AbbVie 295.77B
Novo Nordisk 265.62B
Abbott Laboratories 212.98B
Merck & Co. 193.11B
AstraZeneca 191.67B
Market Cap Rankings